US Patent 11078481 Methods for screening for cancer targets
Patent 11078481 was granted and assigned to KSQ Therapeutics on August, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 2 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+245 characters)
Article
Patent abstract
This invention describes a novel CRISPR/Cas9 target identification platform permitting the discovery of novel genes and pathways involved in the ability of T cells and NK cells to react against and generate an anti-tumor response.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Micah Benson0
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 30 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110784810
Date of Patent
August 3, 2021
0Patent Application Number
201708030
Date Filed
August 3, 2017
0Official Website
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 8 Oct, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11078481 Methods for screening for cancer targets
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11078481
Date of patent
August 3, 2021
Patent application number
20170803
Date Filed
August 3, 2017
Find more entities like US Patent 11078481 Methods for screening for cancer targets
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
